IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. - Wikidata - awgldk - TriplyDB

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q44665278

about

Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 production Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.IL-32 promotes angiogenesis.Preliminary characterization of IL32 in basal-like/triple negative compared to other types of breast cell lines and tissues.Inhibition of IL-32 signaling by bamboo salt decreases pro-inflammatory responses in cellular models of allergic rhinitis Role of th17 cell and autoimmunity in chronic obstructive pulmonary disease.Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis.Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer.Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease.Dysregulation of over-expressed IL-32 in colorectal cancer induces metastasis.Association between IL-32 genotypes and outcome in infection-associated acute lung injury.Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32.Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha Intracellular interaction of interleukin (IL)-32α with protein kinase Cε (PKCε ) and STAT3 protein augments IL-6 production in THP-1 promonocytic cells.IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production.Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors.Interleukin-32-induced thymic stromal lymphopoietin plays a critical role in macrophage differentiation through the activation of caspase-1 in vitro.IL-32-dependent effects of IL-1beta on endothelial cell functions Anti-inflammatory effect of Yu-Ping-Feng-San via TGF-β1 signaling suppression in rat model of COPD.Update in chronic obstructive pulmonary disease 2008.The Role of Mitochondria and Oxidative/Antioxidative Imbalance in Pathobiology of Chronic Obstructive Pulmonary Disease Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis.The cytokine network in chronic obstructive pulmonary disease.Epithelial decision makers: in search of the 'epimmunome'.Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.Role of interleukin-32 in chronic rhinosinusitis Novel insights into the biology of interleukin-32.A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation.Interleukin-32γ suppresses allergic airway inflammation in mouse models of asthma.Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines.Alpha-1 Antitrypsin Deficiency: Beyond the Protease/Antiprotease Paradigm.Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.Synthetic double-stranded RNA induces interleukin-32 in bronchial epithelial cells.Significant association between IL-32 gene polymorphisms and susceptibility to endometrial cancer in Chinese Han women.Effects of leukotriene B4 on interleukin-32, interferon-γ and chemokines in rats with rheumatoid arthritis.Quantification and evaluation of the role of antielastin autoantibodies in the emphysematous lung

P2860

Q24317887-726994E9-3708-4BA1-8F5E-6F482F4D916F Q30411120-1873FC12-3E0B-492A-AA1B-83C6DCDC9A7E Q33555523-FBA80679-37D2-4D8E-B8EC-28887FE86D76 Q34042748-BB080CC8-CA33-4B11-A747-B0AF2BBF9ED0 Q34124598-EA0EB64B-D855-4403-8F83-EB23DB83E150 Q34127425-FE1D7F0E-1CDC-45FE-931E-22F74E1CC5B8 Q34396945-E0F51404-6E4B-4739-B705-E4266172842A Q34621087-CF052AC6-2137-4D8E-B58E-33159DC6B1F5 Q35016934-DBBD8A87-8A09-4937-8888-4ABA752C6DAB Q35134651-0D8A30F9-BFE4-4497-9293-F05E6181FC2D Q35469357-3C93E796-A7A3-42E1-BC2F-B7D8C5851A94 Q35551409-0FA9979F-9FE3-41BB-BEB3-7A32124623CB Q35558297-13A2631A-A561-4D05-9180-20A5B744B3A2 Q35605921-CEB85B04-3252-499D-88B5-2EFC4EF59BF3 Q35641151-99E807A0-49CB-4314-A84F-422FF4398EEF Q35947673-4CF30B36-4FAF-4DBB-B99F-1C8FACC9FCFE Q36246023-389D3BBD-2059-4F1F-82BD-F5A73F120C7E Q36318831-EF450463-DEA2-4718-8477-37E0F402AAA2 Q36562157-3E49DC35-6361-48AB-96BC-0682C8F9C0DE Q36687921-47B09D21-880D-4670-846C-F52587B35C7B Q36907662-FF9631AF-33E6-4A2F-A37B-E6FA821B5163 Q37129422-6D59D899-95BE-4BEB-8564-3653AC7D26C0 Q37366460-4D4DCAE7-F357-4785-A5EA-16D2EBF14D8B Q37422824-04C85017-B4EC-48AE-B0A0-FA1673669C63 Q37571664-D3D22FB2-96DC-4D22-9D2C-B9F2118A1BFE Q37581596-246DC757-24B3-4FEC-8AA0-0C49146A08CF Q37589389-C4E7224B-B3B5-4678-8CDD-D10033AA69BB Q37774241-282D4736-CFA3-4719-8906-A4B41131BD07 Q37836078-C11B6D72-77F1-4127-A88C-C31137B2B212 Q38067583-411135B3-D913-4BC8-81FF-6F7953829D11 Q38086768-4AC31A6A-5D66-42DF-8DEC-E038BA8638FC Q38334454-878082E6-BF6F-4D1C-860F-98D2E2429DF8 Q38443719-3C014111-A74B-4EE2-B94F-A891E744E132 Q38810990-BFC41803-44D3-4D2D-8FB9-58D42F1F8CBC Q38937849-9FBF9B68-2052-4561-B7CD-92544DA9F66B Q39580319-C9E8E188-6C7C-4008-A4E0-F8D8BE464EB9 Q41119588-EC05CCC1-3E18-40F1-9D3E-43431FB0728B Q41495034-CF610225-4F1A-4968-8FD9-8DF10DC653AA Q41623500-9E4452AC-961D-4C73-AFBC-184D15B2DA78 Q41888256-FA5BBBEB-243D-4905-BDBF-A5B0E6B60490

P2860

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q44665278

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

@en

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

@nl

type

label

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

@en

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

@nl

prefLabel

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

@en

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

@nl

P1433

Q44665278-340041D6-3560-4B06-95DE-97152B768970

P1476

Q44665278-B5A1C6E5-6DDE-4A19-96C4-93A4589DC17E

P2093

Q44665278-53D10A9D-FED3-4076-8A5C-52084C5DAB3A

Q44665278-54ED5052-3BF4-4951-ADB0-F9A8F7513276

Q44665278-606E80CE-F44E-4F5E-8C90-47E9C9A0F05B

Q44665278-820EE85A-EB6C-4782-B773-FCDDA87CDD46

Q44665278-A5656541-E98B-4F95-987A-0846926ADE0B

Q44665278-B6BEE148-9D1A-48F1-AD40-D6FF9129D256

Q44665278-EC920A5D-118B-4F7E-B572-B10E8D3197CB

P2860

Q44665278-07FDA8D2-B58A-4A4B-8D34-15CA5F1702BD

Q44665278-0B9F1E04-1460-4603-A781-B3E2C631C4F6

Q44665278-0F4B1472-C2B5-4144-9FA4-9C7F82376FC7

Q44665278-0F845B80-A972-47F6-9EFE-1FE0CA9D4E05

Q44665278-14E23B46-3A18-4AB2-B0C5-150857C2A4E5

Q44665278-15B0C417-D5AC-4E58-88DC-98755502807E

Q44665278-1B41A78B-6826-44F3-8ED9-6C3F312AD5D4

Q44665278-267DB715-74EA-45A2-8796-5BD470FD5747

Q44665278-3C94BA7A-048E-4712-BB5C-BE1AAC505656

Q44665278-3D7482D6-9DCF-45E9-B581-E68EA3477B27

P304

Q44665278-60CDC20E-39C7-4C93-AE4C-1B3DA096E68F

P31

Q44665278-7E161054-0A04-4720-9C65-B02674246BDE

P356

Q44665278-0666410B-8512-4324-BAE8-BD029683CE4F

P407

Q44665278-EC3FC288-0420-46E4-980A-D10D021CDD3E

P433

Q44665278-262D960C-B434-4154-9D66-760619AFB6D9

P478

Q44665278-486DF7D2-B7BA-4969-8909-4C2D38457D19

P50

Q44665278-06710247-1DE6-49E7-9D7D-9066567BC901

Q44665278-33EADD54-355C-4080-8BCC-BC94B223AD5E

Q44665278-5C6A9379-CF74-4229-B3AF-13D2BB3304E3

Q44665278-5D885647-992B-4D4A-8B6C-597ABB938B63

Q44665278-6FBA9FE6-4BA1-47EA-8D09-C678C5342263

Q44665278-8BB5AD2A-6EAD-4654-A347-40256485F3BF

Q44665278-A75B74E9-C443-4A49-8E00-F1B93D94FA87

P577

Q44665278-8A1D0B96-832E-4EBC-8E46-CA7E43F6F3E7

P698

Q44665278-7915DF08-4FAE-4E6F-A975-8F5AEF9898DA

P921

Q44665278-30E09649-3D93-4581-94F1-960C77C4F1DA

P356

RCCM.200804-646OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease

@en

P2093

Charles A Dinarello

http://www.w3.org/2001/XMLSchema#string

Elisabetta Balestro

http://www.w3.org/2001/XMLSchema#string

Federico Rea

http://www.w3.org/2001/XMLSchema#string

Fiorella Calabrese

http://www.w3.org/2001/XMLSchema#string

Kim Lokar-Oliani

http://www.w3.org/2001/XMLSchema#string

Piero Maestrelli

http://www.w3.org/2001/XMLSchema#string

Renzo Zuin

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods

Hypothesis: does COPD have an autoimmune component?

Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema

An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema

Inflammation and cancer: back to Virchow?

Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism

The nature of small-airway obstruction in chronic obstructive pulmonary disease

IL-32, a proinflammatory cytokine in rheumatoid arthritis.

Autoantibodies in patients with chronic obstructive pulmonary disease

P304

894-901

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200804-646OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Lunardi

Graziella Turato

Simonetta Baraldo

P577

2008-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18703789

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease